Fitbit Gets Into the Diabetes Business


Advertisement

Want to learn more about Diabetes? Sign up for our weekly newsletter, full of recipes, advice and more! [1]

Fitbit, a company that has become well-known for its activity trackers (wearable fitness devices that monitor things like heart rate and steps walked), recently announced it was making a substantial investment in diabetes technology. The San Francisco-based firm said it had made a $6 million investment[2] in the technology company Sano.

Fitbit Diabetes Business[3]
Logo courtesy of Fitbit.

Founded in 2011, Sano, also located in San Francisco, has focused on developing a biometric wearable mobile sensor that continuously monitors blood sugar levels. The company describes the device, which is contained in a small patch, as “completely painless” and says that it can help users understand how their diet and exercise affects their metabolism. Business analysts speculated that if Fitbit were to incorporate blood-sugar monitoring into its existing devices it could substantially increase its sales.

According to Fitbit CEO James Park, the investment in Sano “fits into our strategy of looking beyond the device and thinking more about (health) solutions. I think the complete solution comes in the form of having some monitoring solution that is coupled with a display and a wearable that can give you the interventions at the right moment.”

Sano’s device is expected to come onto the market in early 2019. Although it will most likely be aimed at people with Type 1[4] or Type 2 diabetes[5], the company thinks it might also be used by people with prediabetes[6] or by users just who want to know how their lifestyle affects their blood sugar.

Click here to see Fitbit’s latest activity trackers.[7]

Want to learn more about health technology? Watch the videos “Continuous Glucose Monitoring”[8] and “Diabetes and Technology.”[9]

Endnotes:
  1. Want to learn more about Diabetes? Sign up for our weekly newsletter, full of recipes, advice and more! : https://www.diabetesselfmanagement.com/newsletter/
  2. $6 million investment: https://www.cnbc.com/2018/01/05/fitbit-invests-in-sano-diabetes-tech-start-up-to-catch-apple.html
  3. [Image]: //cdn.diabetesselfmanagement.com/2018/05/Gustaitis_050318v2.png
  4. Type 1: https://www.diabetesselfmanagement.com/diabetes-resources/definitions/type-1-diabetes/
  5. Type 2 diabetes: https://www.diabetesselfmanagement.com/diabetes-resources/definitions/type-2-diabetes/
  6. prediabetes: https://www.diabetesselfmanagement.com/blog/stopping-prediabetes-tracks/
  7. Click here to see Fitbit’s latest activity trackers.: https://amzn.to/2HQ6dJu
  8. “Continuous Glucose Monitoring”: https://www.diabetesselfmanagement.com/videos/continuous-glucose-monitoring/
  9. “Diabetes and Technology.”: https://www.diabetesselfmanagement.com/videos/diabetes-and-technology/

Source URL: https://www.diabetesselfmanagement.com/blog/fitbit-diabetes-business/


Joseph Gustaitis: Joseph Gustaitis is a freelance writer and editor based in the Chicago area. (Joseph Gustaitis is not a medical professional.)

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.